Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cethromycin vs clarithromycin for treatment of community-acquired pneumonia in adults
2006-002110-35Phase 3Completed
- Sponsor
- Advanced Life Sciences Holdings
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cethromycin in community-acquired pneumonia (CAP) (2 arms), sponsored by Advanced Life Sciences Holdings. Primary endpoint: Clinical cure rate at Test-of-Cure visit. Started Jun 2006; status: completed.
02
Drugs
cethromycin
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on 2006-002110-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002110-35.